Report an error

Spotted something inaccurate in “GLP-1 Agonists Cut Psoriasis, HS, and Eczema Burden via Immune-Metabolic Pathways”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.